Reyes Clinical Research, Inc

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Diabetic eye disease1 trial
• Obesity1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Novo Nordisk A/S4 trials

Running trials

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Novo Nordisk A/S· Source

Closed trials

• Completed

  A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

  NCT05514535· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight

  NCT05486065· Phase 2· Novo Nordisk A/S· Source

• Completed

  A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

  NCT05035082· Phase 4· Novo Nordisk A/S· Source